Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis

Figure 2

BZA suppressed cardiac hypertrophy in vivo. (a) Gross heart (). (b) The results of the HW/BW and HW/TL ratio ( = 12–15). (c) The cross-sectional areas in the sham and AB groups with and without BZA (). (d) The mRNA levels of ANP, BNP, α-MHC, and β-MHC ().

(a)

(b)

(c)

(d)